Skip to content

The safety and clinical efficacy of electro-thumbtack needle in the prevention of acute mountain sickness : a prospective, randomised, controlled study

The safety and clinical efficacy of electro-thumbtack needle in the prevention of acute mountain sickness: a prospective, randomised, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000065
Enrollment
Unknown
Registered
2023-12-04
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute mountain sickness

Interventions

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. The subject is at an altitude of >= 3000m during the test; 2. The subject has not arrived on the plateau for more than 48 hours; 3. l LLSS score >= 3 and at least 1 headache; 4. Age >= 18 years and < 65 years; 5. No experience of living and working in a plateau within 2 months; 6. Not having participated in another clinical trial within 3 months; 7. Voluntary participation in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. 2 weeks before entering the plateau with dizziness, chronic headache, cardiovascular and cerebrovascular diseases, chronic respiratory diseases, chronic digestive system diseases; 2.combined with other serious diseases such as malignant tumors and mental illnesses and other diseases that affect the evaluation of this study; 3.Those who are contraindicated to electro-snap needling: such as those who have cardiac pacemakers; 4. taking preventive drugs (including acetazolamide, dexamethasone, nifedipine and phosphodiesterase-3 inhibitors) within 2 weeks before plateauing.

Design outcomes

Primary

MeasureTime frame
Incidence of AMS;

Secondary

MeasureTime frame
Bp;Oxygen saturation;Microcirculation indicators;VAS of headache;HR;the severity of AMS;GSQS;SSS;LLSS;AMS clinical function score;

Countries

China

Contacts

Public ContactLiu Jia

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

marie_liujia@sina.cn+86 188 1087 7011

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026